AzTrials
AzTrials

Patient Care in Intensive Care Unitsoral careNCT07635225

Investigating the Effect of Oral Care Frequency on Oral Mucosal Tissue Integrity in Critically Ill Patients.

A study testing Oral care based on assessment scale and Routine oral care in people with Patient Care in Intensive Care Units, run by Balikesir University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to investigate the effect of oral care frequency on oral mucosal tissue integrity in intensive care patients. Read more about this study

Who is it for?
Ages 18 to 95 months
Conditions the study is for
Patient Care in Intensive Care Units
What is being tested?
Oral care based on assessment scale and Routine oral care
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Aug 2025to 1 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 95 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • •Patients admitted to the adult intensive care unit:
  • Patients aged 18 and over
  • Patients who agreed to participate in the study (voluntary informed consent obtained from the patient or their relatives)
  • Patients who are not allergic to the contents of the oral care solution to be used were included in the study.

Who cannot join

  • • Patients under 18 years of age
  • Patients with oral bleeding
  • Patients with thrombocytopenia
  • Patients who have undergone oral surgery
  • Patients who did not consent to the study (either from the patient themselves or a relative) were not included in the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Balıkesir Üniversitesi Sağlık Uygulama ve Araştırma Hastanesi

    Balıkesir, Altıeylül, 10100

Other trials in Turkey (Türkiye)

About this study

This study aims to investigate the effect of oral care frequency on oral mucosal tissue integrity in intensive care patients.

Read the detailed description

Research data will be collected from the Adult Intensive Care Units of Balıkesir University Health Practice and Research Hospital. Patients meeting the inclusion criteria will be informed about the research, and those who volunteer to participate, or their relatives, will provide written/verbal consent using an Informed Consent Form. The assignment of patients to different groups will be determined using simple randomization on the randomizer.org website. Patients admitted to the intensive care unit at the start of the study will be assigned to control and intervention groups according to the numbers on the randomizer.org website. Oral care swabs will be prepared for each patient in both the control and intervention groups, with four swabs per patient, moistened with a 0.25% chlorhexidine gluconate solution. If the patient is conscious, they will be placed in a comfortable position; if unconscious, their head will be positioned sideways towards the person performing the procedure. Oral care will be performed on the patient, covering all teeth, inner cheeks, under the tongue, gums, and other soft tissues. After the patient's oral care procedure is complete, the patient will be returned to their original position, and the procedure will be finished. Each care session will last at least 2 minutes. Patients in the control group will receive oral care four times a day, every six hours. Patients in the intervention group will receive oral care at a frequency determined individually based on their scores on the intensive care oral care frequency assessment scale. Patients in both groups will be evaluated at the beginning and throughout the intervention using the oral mucosa assessment scale to assess the effect of the oral care on the oral mucosa. The intervention is planned to continue for five days, and the results will be recorded.

Being tested
Oral care based on assessment scale, Routine oral care
Keywords
intensive care, intensive care nurse, nurse, oral care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Oral care based on assessment scaleOther

    Oral care frequency is determined according to the Intensive Care Oral Care Frequency Assessment Scale.

  • Routine oral careOther

    Oral care is provided according to standard intensive care unit routine practice.

Study groups in NCT07635225
Study groupRoleWhat they receive
Individualized oral care frequency groupExperimentalOral care is provided according to the Intensive Care Oral Care Frequency Assessment Scale score during the follow-up period.
Receives: Other: Oral care based on assessment scale
Routine oral care groupActive comparatorOral care is provided according to routine unit practice, such as 4 times daily, during the follow-up period.
Receives: Other: Routine oral care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intensive Care Unit Oral Care Frequency Assessment Scale (Day 1 to Day 5)

    9 points 12*1 10-19 points 3*1 20-29 points 4*1 30 and above 6*1

    Measured: For 5 days after being admitted to intensive care

Secondary outcomes (1)
  1. Oral mucosa assessment scale

    The scale evaluates five sections of the mouth and its parts (lips, oral mucosa, gingiva, tongue, teeth, and saliva). Each question is scored from 1 to 4. The lowest possible score is "5" and the highest is "20". A score of 0-5 indicates normal oral mucosal health, 6-20 indicates mild dysfunction, 11-15 indicates moderate dysfunction, and 16-20 indicates severe dysfunction. A low score indicates good oral mucosal health, while a high score indicates poor oral mucosal health.

    Measured: 9:00 AM every day for 5 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2026
  2. Study start20 Aug 2025
  3. Primary completion20 Oct 2025
  4. Study completion1 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Study data was collected in two stages.
Masking
Single blind
Who is masked
Participant
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07635225
Sponsor's protocol ID
E.521870
Acronym
oral care
Status last verified
Jun 2026
First submitted
13 Apr 2026
Last updated
9 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All individual participant data collected, all individual participant data that forms the basis of the results in a publication.

Publications

  • Dogu Kokcu O, Terzi B. Development of an intensive care oral care frequency assessment scale. Nurs Crit Care. 2022 Sep;27(5):667-675. doi: 10.1111/nicc.12529. Epub 2020 Jul 6.

    PubMed 32633044

Questions about this trial

What is this clinical trial studying?

A study testing Oral care based on assessment scale and Routine oral care in people with Patient Care in Intensive Care Units, run by Balikesir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intensive Care Unit Oral Care Frequency Assessment Scale (Day 1 to Day 5) (time frame: For 5 days after being admitted to intensive care). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07635225, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in